| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.009 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |